Uniklar Suspension Hazirlamak Icin Kuru Powder 125 Mg/5Ml

Uniklar Suspension is a medication containing the active ingredient clarithromycin, formulated as a dry powder for oral suspension. This pharmaceutical preparation, manufactured in Turkey, is primarily prescribed for bacterial infections affecting various body systems. This article provides detailed information about the medication’s composition, therapeutic uses, administration guidelines, and safety considerations.

Composition and Pharmaceutical Form

Uniklar Suspension Hazirlamak Icin Kuru Powder contains clarithromycin 125 mg per 5 ml as its active pharmaceutical ingredient. The term “Hazirlamak Icin Kuru Powder” refers to the dry powder form that needs reconstitution with water before administration. The formulation includes several excipients such as sucrose, potassium sorbat, maltodextrin, silicon dioxide, xanthan gum, titanium dioxide, and fruit flavoring to enhance palatability and stability. The granular powder, once reconstituted, forms a suspension that can be measured accurately for proper dosing.

Mechanism of Action

Clarithromycin belongs to the macrolide antibiotic class, which works by inhibiting bacterial protein synthesis. It specifically binds to the 50S ribosomal subunit of susceptible bacteria, preventing the addition of amino acids to the growing peptide chain. This mechanism effectively halts bacterial growth and replication. Unlike antibiotics that directly kill bacteria (bactericidal), clarithromycin is primarily bacteriostatic, meaning it prevents bacterial multiplication and allows the body’s immune system to eliminate the infection.

Therapeutic Indications

Respiratory Tract Infections

Uniklar Suspension is indicated for the treatment of upper respiratory tract infections such as pharyngitis (throat infection), tonsillitis (inflammation of the tonsils), and acute maxillary sinusitis caused by susceptible organisms including Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis. It is also effective against lower respiratory tract infections such as community-acquired pneumonia and exacerbations of chronic bronchitis.

Ear Infections

The medication is particularly useful in treating acute otitis media (middle ear infection) in children, which is often caused by common respiratory pathogens. Its effectiveness against these infections makes it a valuable option in pediatric practice.

Skin and Soft Tissue Infections

Uniklar can be prescribed for uncomplicated skin and soft tissue infections of mild to moderate severity, including those caused by Staphylococcus aureus and Streptococcus pyogenes. These include conditions such as impetigo, folliculitis, cellulitis, and erysipelas.

Helicobacter Pylori Eradication

As part of combination therapy, clarithromycin is used in the eradication of Helicobacter pylori, a bacterium associated with peptic ulcers. The standard regimen typically includes clarithromycin alongside other antibacterial agents and an acid-suppressing medication.

Dosage and Administration

Pediatric Dosing

For children between 6 months and 12 years of age, the recommended dosage is 7.5 mg/kg of body weight administered twice daily. The medication should be given at 12-hour intervals to maintain consistent blood levels. Treatment typically continues for 5 to 10 days, depending on the nature and severity of the infection.

Weight-Based Dosing Guide

The following weight-based dosage chart provides guidance for administration:

• 8-11 kg: 2.5 ml (62.5 mg) twice daily

• 12-19 kg: 5 ml (125 mg) twice daily

• 20-29 kg: 7.5 ml (187.5 mg) twice daily

• 30-40 kg: 10 ml (250 mg) twice daily

For children weighing less than 8 kg, a dose of 0.30 ml/kg (7.5 mg/kg) twice daily is recommended.

Administration Instructions

Uniklar Suspension can be administered with or without food and may also be given with milk. To minimize the bitter aftertaste, drinking juice or water shortly after taking the suspension is recommended. Each dose should be measured accurately using the provided measuring device.

Special Populations

For patients with moderate to severe renal impairment (creatinine clearance less than 30 ml/min), the daily dose should be reduced by 50%. The maximum daily dose for children with severe renal impairment is 500 mg, and treatment duration should not exceed 14 days in these cases.

Contraindications

Uniklar Suspension is contraindicated in patients with known hypersensitivity to macrolide antibiotics or any of the excipients in the formulation. Additionally, it should not be co-administered with ergot alkaloids (ergotamine or dihydroergotamine), oral midazolam, astemizole, cisapride, pimozide, or terfenadine due to the risk of serious cardiac arrhythmias including QT prolongation and torsades de pointes.

The medication is also contraindicated in patients with a history of QT prolongation or ventricular cardiac arrhythmia. Careful consideration should be given before prescribing clarithromycin to patients taking medications known to prolong the QT interval.

Special Warnings and Precautions

Hepatic and Renal Impairment

Caution should be exercised when administering clarithromycin to patients with impaired hepatic function, as the drug is primarily excreted by the liver. Cases of fatal hepatic failure have been reported, necessitating prompt discontinuation if signs of hepatic disease develop, including anorexia, jaundice, dark urine, pruritus, or abdominal tenderness.

Similarly, for patients with renal insufficiency, dose adjustment is required based on the severity of impairment.

Antimicrobial Resistance

Long-term use of clarithromycin may lead to the emergence of resistant organisms, including non-susceptible bacteria and fungi. If superinfections occur, appropriate therapy should be initiated promptly. There is also potential for cross-resistance between clarithromycin and other macrolide drugs, as well as lincomycin and clindamycin.

Drug Interactions

Significant Interactions

Clarithromycin interacts with several medications, requiring careful monitoring:

1. Ritonavir: Concomitant administration results in inhibition of clarithromycin metabolism, increasing its plasma concentration. While no dosage reduction is necessary for patients with normal renal function, dose adjustments are required for those with renal impairment.

2. Fluconazole: Co-administration may increase clarithromycin plasma levels, though significant dose adjustment is typically not required.

3. Other medications: Interactions with cisapride, pimozide, ergot alkaloids, and certain statins may lead to serious adverse effects and should be avoided.

Adverse Reactions

Common Side Effects

The most frequently reported adverse reactions include:

• Gastrointestinal disturbances: nausea, vomiting, diarrhea, abdominal pain

• Taste alterations (dysgeusia)

• Headache

These effects are generally mild and transient, resolving after discontinuation of treatment.

Serious Adverse Effects

Though rare, serious adverse effects may include:

• Hepatotoxicity (liver damage)

• Severe allergic reactions

• QT prolongation and cardiac arrhythmias

• Clostridium difficile-associated diarrhea

Patients should seek immediate medical attention if they experience symptoms such as severe diarrhea, jaundice, rash, or significant cardiac symptoms.

Storage and Handling

The dry powder should be stored at room temperature, protected from moisture and light. After reconstitution, the suspension should be stored according to the manufacturer’s instructions, typically at room temperature or refrigerated, and used within the specified timeframe. The reconstituted suspension should be shaken well before each use to ensure uniform distribution of the active ingredient.

Conclusion

Uniklar Suspension Hazirlamak Icin Kuru Powder 125 Mg/5Ml is an effective antibiotic for treating various bacterial infections, particularly in the pediatric population. Its broad spectrum of activity against common pathogens makes it valuable for respiratory, skin, and other infections. As with all antibiotics, it should be used judiciously, following healthcare provider instructions precisely to maximize therapeutic benefits while minimizing the risk of adverse effects and antimicrobial resistance.

Product Information Table

It is essential to consult a healthcare provider before using this medication, as individual medical conditions, potential drug interactions, and specific infection characteristics will determine the appropriateness and exact regimen of treatment.